Zynex: Deteriorating Fundamentals and Signs of Reimbursement Pressure – Night Market Research

Zynex: Deteriorating Fundamentals and Signs of Reimbursement Pressure –  Night Market Research

Zynex: Deteriorating Fundamentals and Signs of Reimbursement Pressure – Night Market Research

Revenue growth masks deteriorating profitability: operating margins trend lower (64% lower past two years) as Zynex accelerates hiring in face of early signs of reimbursement pressure. Tricare becomes first large health plan since Medicare to drop ZYXI’s device for one of its largest indications citing poor efficacy - we expect other payors to follow Zynex…

Zynex: Deteriorating Fundamentals and Signs of Reimbursement Pressure –  Night Market Research

Zynex: Deteriorating Fundamentals and Signs of Reimbursement Pressure – Night Market Research

Zynex: Deteriorating Fundamentals and Signs of Reimbursement Pressure –  Night Market Research

Zynex: Deteriorating Fundamentals and Signs of Reimbursement Pressure – Night Market Research

Zynex: Deteriorating Fundamentals and Signs of Reimbursement Pressure –  Night Market Research

Zynex Medical Products, Non-Invasive Pain Management

Zynex: Deteriorating Fundamentals and Signs of Reimbursement Pressure –  Night Market Research

Newsbriefs Journal of Nuclear Medicine

Zynex: Deteriorating Fundamentals and Signs of Reimbursement Pressure –  Night Market Research

Long-term efficacy and safety of renal denervation in the presence of antihypertensive drugs (SPYRAL HTN-ON MED): a randomised, sham-controlled trial - The Lancet

Zynex: Deteriorating Fundamentals and Signs of Reimbursement Pressure –  Night Market Research

Zynex: Deteriorating Fundamentals and Signs of Reimbursement Pressure – Night Market Research

Zynex: Deteriorating Fundamentals and Signs of Reimbursement Pressure –  Night Market Research

Zynex: Abusive Pricing Model Unsustainable (NASDAQ:ZYXI)

Zynex: Deteriorating Fundamentals and Signs of Reimbursement Pressure –  Night Market Research

Zynex: Deteriorating Fundamentals and Signs of Reimbursement Pressure – Night Market Research

Zynex: Deteriorating Fundamentals and Signs of Reimbursement Pressure –  Night Market Research

ZYXI: A case study - by Adu Subramanian

Zynex: Deteriorating Fundamentals and Signs of Reimbursement Pressure –  Night Market Research

Cost-effectiveness and value of information analyses of Bruton's tyrosine kinase inhibitors in the treatment of relapsed or refractory mantle cell lymphoma in the United States

Zynex: Deteriorating Fundamentals and Signs of Reimbursement Pressure –  Night Market Research

Zynex: Turnaround Nears End – UnitedHealthcare Cuts TENS Reimbursement (ZYXI)